# VerifierReport - 2026-05-07-docs-hygiene-mainline-cleanup

## 1) Verification Summary
- Verdict: PASS
- Release recommendation: GO
- Gate 4 blocking defects (P0/P1): 0
- Verifier: codex
- Time: 2026-05-07T07:28:00Z

## 2) Acceptance Criteria Verification
| AC ID | Status | Evidence |
|---|---|---|
| AC-01 | PASS | `docs/TASK-INDEX.md` now names Gold and Glory Brain, Campaign Creative Agent north star, and the next mainline work: distribution handoff, human feedback, and brain refresh. |
| AC-02 | PASS | Version-marker search confirms `PRODUCT.md` starts at v0.153/v0.152 and no longer has the stale v0.150 appended tail; `CHANGELOG.md` starts at v0.153/v0.152 and no longer has the duplicate v0.135-v0.138 tail. |
| AC-03 | PASS | `Test-Path docs/workflow/runs/2026-05-07-production-english-reference-ux` returned `false`. |

## 3) Six-Class Check
| Class | Result | Notes |
|---|---|---|
| Functional | PASS | Docs now route operators to the intended mainline. |
| Regression | PASS | Existing canonical recent changelog entries were preserved. |
| Data integrity | PASS | No runtime data or persisted knowledge packs were touched. |
| Security | PASS | No env files, keys, auth paths, or forbidden backend services touched. |
| UX/Product | PASS | Active task map now matches the marketer-first product direction. |
| Release readiness | PASS | Backend/frontend builds pass; release guard still pending before deployment. |

## 4) Commands Run
| Command | Result |
|---|---|
| `git diff --check` | PASS |
| `Select-String` marker checks for `PRODUCT.md` and `CHANGELOG.md` | PASS |
| `Test-Path docs/workflow/runs/2026-05-07-production-english-reference-ux` | PASS (`false`) |
| `npm run build` in `h5-video-tool-api` | PASS |
| `npm run build` in `h5-video-tool` | PASS |

## 5) Issues
| ID | Severity | Description | Status |
|---|---|---|---|
| None | N/A | No P0/P1/P2 issues found. | Closed |

## 6) Residual Risks
- `PRODUCT.md` historical mojibake remains out of scope.
- Existing Vite dynamic/static import warning remains unrelated and non-blocking.
